Carregant...
165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency
BACKGROUND: To compare the efficacy of icatibant in early versus late treated attacks of hereditary angioedema. METHODS: Thirty-one patients received 30 mg icatibant subcutaneously at various times for 121 swelling attacks. The time periods between onset of attacks and icatibant injection, icatibant...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
World Allergy Organization Journal
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3513132/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.WOX.0000411922.50578.13 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|